This drug called retatrutide probably helps people with obesity or type 2 diabetes control their blood sugar better, especially if they take a higher dose.

Pro

Against

Evidence from Studies

Supporting (1)

Community contributions welcome

Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials

Systematic Review With Meta-Analysis

Human

2025

Contradicting (0)

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials

Score: 57

DOI: 10.1080/08998280.2025.2456441

Similar Assertions

A drug called retatrutide, taken once a week, helped lower blood sugar a lot in people with type 2 diabetes over 9 months — more than a placebo or another diabetes drug.

86%

A once-a-week shot called retatrutide may help lower blood sugar levels in people who are overweight, obese, or have type 2 diabetes—even if they don’t lose weight.

85%

Taking a drug called retatrutide every week for about 6 to 12 months probably helps people with obesity or type 2 diabetes lose belly fat and drop their BMI by noticeable amounts.

78%

A drug called retatrutide probably helps people with obesity or type 2 diabetes lose about 14% of their body weight when given as a weekly shot for up to a year, and higher doses seem to lead to more weight loss.

76%

Adults with obesity or type 2 diabetes who take a weekly 12 mg dose of retatrutide are way more likely—over 70 times more—to lose at least 15% of their body weight in less than a year compared to those taking a fake pill.

75%